Loading...
Loading...
Analysts at Citigroup initiated coverage of
Anthera Pharmaceuticals Inc ANTH with a Buy rating. The target price for Anthera Pharmaceuticals is set to $15. Anthera Pharmaceuticals shares closed at $7.98 on Wednesday.
Analysts at Euro Pacific initiated coverage on
Viper Energy Partners LP VNOM with a Buy rating. The target price for Viper Energy Partners is set to $19. Viper Energy Partners shares closed at $15.71 on Wednesday.
UBS initiated coverage on
Stanley Black & Decker, Inc.SWK with a Buy rating. The target price for Stanley Black & Decker is set to $120. Stanley Black & Decker shares closed at $101.70 on Wednesday.
Analysts at Nomura initiated coverage on
Constellation Brands, Inc. STZ with a Neutral rating. The target price for Constellation Brands is set to $130. Constellation Brands shares closed at $131.16 on Wednesday.
Analysts at Imperial Capital initiated coverage of
Voxeljet AG (ADR)VJET with a In-line rating. The target price for Voxeljet is set to $6. Voxeljet shares closed at $5.77 on Wednesday.
UBS initiated coverage of
W W Grainger Inc GWW with a Neutral rating. The target price for W W Grainger is set to $225. W W Grainger shares closed at $222.43 on Wednesday.
Analysts at Credit Suisse initiated initiated coverage on
Loading...
Loading...
with a Neutral rating. The target price for Brixmor Property Group is set to $28. Brixmor Property Group shares closed at $23.68 on Wednesday.
Citigroup initiated coverage on
MacroGenics Inc MGNX with a Neutral rating. The target price for MacroGenics is set to $31. MacroGenics shares closed at $27.54 on Wednesday.
Analysts at UBS initiated coverage on
WESCO International, Inc. WCC with a Neutral rating. The target price for WESCO International is set to $57. WESCO International shares closed at $54.94 on Wednesday.
Analysts at Oppenheimer initiated coverage on
Black Knight Financial Services Inc BKFS with a Perform rating. Black Knight Financial Services shares closed at $34.99 on Wednesday.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in